S�SS MicroTec AG / Key word(s): Strategic Company Decision/Change in Forecast 06.11.2013 20:10 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Garching, November 6, 2013 - SUSS MicroTec, a leading supplier of equipment and process solutions for the semiconductor and related markets, announces a strategic management decision. Due to a reevaluation of our business situation in permanent bonding and the ongoing losses in this product line, the management has decided to expand the restructuring measures, which have been taken in the second quarter this year, and to cease production of cluster systems for permanent bonding applications. The development and production of the successful manual permanent bonding systems are not affected by this strategic action. In this context one-off expenses of approximately EUR 8.3 million can be expected in the fourth quarter 2013. This one-off effect includes EUR 6.7 million for write-offs on inventories (raw materials, unfinished goods as well as demonstration tools) and EUR 1.6 million of precautionary provisions formed for single customer projects. With this move the management expects to pronouncedly reduce the losses of the Substrate Bonding Division. SUSS MicroTec today announces a revision of the full year guidance 2013. The sales expectation of formerly EUR 150 million is revised to a bandwidth of EUR 125 - EUR 135 million. The reason is a potential delay in the sales recognition of several machines, which have already been shipped but are still waiting for final acceptance of the customer. The tools include temporary and permanent bond cluster systems for international customers. Due to the lower overall sales level, the EBIT will most likely not reach in the original range of minus EUR 10 to minus EUR 15 million. Taking the one-off expenses into account an EBIT in the range of minus EUR 22 to minus EUR 27 million can be expected. The EBIT for 2013 includes approximately EUR 14.3 million charges for the restructuring of the product line permanent bonding. For the fourth quarter 2013, the Company expects a robust order intake in the range of EUR 30 - EUR 40 million. Contact: SUSS MicroTec AG Franka Schielke Schleissheimer Strasse 90 85748 Garching, Deutschland Tel.: +49 (0)89 32007-161 Fax: +49 (0)89 32007-451 Email: franka.schielke@suss.com 06.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: S�SS MicroTec AG Schleissheimer Strasse 90 85748 Garching Germany Phone: +49 (0)89 32007-161 Fax: +49 (0)89 32007-451 E-mail: ir@suss.com Internet: www.suss.com ISIN: DE000A1K0235 WKN: A1K023 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: SÃ?SS MicroTec AG: Announcement of a Strategic
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sales Focus Inc. Awarded as Leading Medical Outsourcing Service
Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...
Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry
Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....
Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential
Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...
Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled
BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...
Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact
Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...
Continue Reading